Evidence map›Paper›PMID 28320965›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Deficiency of a sulfotransferase for sialic acid-modified glycans mitigates Alzheimer's pathology.

Zui Zhang, Yoshiko Takeda-Uchimura, Tahmina Foyez, Shiori Ohtake-Niimi, Narentuya, Hiroyasu Akatsu, Kazuchika Nishitsuji, Makoto Michikawa, Tony Wyss-Coray, Kenji Kadomatsu and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Beta3Gn-T7 Is a Keratan Sulfate β1,3Frontiers in neuroanatomy · 2022
    Article
  15. Article
  16. Review
  17. Glycosaminoglycans in Neurodegenerative Diseases.Advances in experimental medicine and biology · 2021
    Review
  18. Review
  19. Genome-wide transcriptomic analysis of microglia reveals impaired responses in aged mice after cerebral ischemia.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Zui ZhangDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Yoshiko Takeda-UchimuraDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Tahmina FoyezDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Shiori Ohtake-NiimiDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
NarentuyaDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Hiroyasu AkatsuChoju Medical Institute, Fukushimura Hospital, Toyohashi, 441-8124, Japan.
Kazuchika NishitsujiDepartment of Molecular Pathology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, 770-8503, Japan.
Makoto MichikawaDepartment of Biochemistry, Nagoya City University Graduate School of Medicine, Nagoya, 467-8601, Japan.
Tony Wyss-CorayDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305.
Kenji KadomatsuDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Kenji UchimuraDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan; arumihcu@med.nagoya-u.ac.jp.
Nagoya University · JPChoju Medical Institute · JPNagoya City University · JPNational Center for Geriatrics and Gerontology · JPStanford University · USTokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously showed that microglial keratan sulfate (KS) was induced in amyotrophic lateral sclerosis. However, the functional roles of the glycan and its synthetic enzyme in neurodegenerative diseases, such as Alzheimer's disease (AD), a progressive disorder, are unclear. In our study, KS modified with sialic acids having a molecular mass of 125-220 kDa and the carbohydrate sulfotransferase GlcNAc6ST1 were up-regulated in the brains of two transgenic mouse models (J20 and Tg2576) and the brains of patients with AD. GlcNAc6ST1-deficient J20 (J20/GlcNAc6ST1

Indexed as

Aged, 80 and overAlzheimer DiseaseAmyloid beta-Protein PrecursorAnimalsCarbohydrate SulfotransferasesDisease Models, AnimalFemaleHumansKeratan SulfateMaleMice, TransgenicMicrogliaN-Acetylneuraminic AcidPhagocytosisPlaque, AmyloidPolysaccharidesAmyloid beta-Protein PrecursorCarbohydrate SulfotransferasesKeratan SulfateN-Acetylneuraminic AcidPolysaccharidesSulfotransferasesAlzheimer's diseasecarbohydrate-recognizing receptorsmicrogliasialic acidsulfotransferase

Identifiers

PMID28320965
PMCPMC5389269
OpenAlexW2600217900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.